KRYS · Krystal Biotech Inc
United States · RS rating 76 · As of 2026-10-14
| Price | 330.69 USD |
|---|---|
| 1-day change | +3.0% |
| RS rating (overall / 1M / 3M / 12M) | 76 / 54 / 50 / 94 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 42 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -36.1% |
| Sales growth Q/Q | +9.5% |
| Distance from 52-week high | +12.6% |
| Market cap (USD) | $7.9B |